Reorganization of ErbB Family and Cell Survival Signaling after Knock-down of ErbB2 in Colon Cancer Cells-Reference-Cited by-同舟云学术

Reorganization of ErbB Family and Cell Survival Signaling after Knock-down of ErbB2 in Colon Cancer Cells

Published:2005-07 Issue:29 Volume:280 Page:27383-27392
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Hu Yi Peter,Venkateswarlu Srinivas,Sergina Natalia,Howell Gillian,Clair Patricia St.,Humphrey Lisa E.,Li Wenhui,Hauser Jennie,Zborowska Elizabeth,Willson James K.V.,Brattain Michael G.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference70 articles.

1. Growth factor signaling by receptor tyrosine kinases

2. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins

3. Protease-activated Receptor 2 in Colon Cancer

4. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

5. The erbB Family: Targets for Therapeutic Development Against Cancer and Therapeutic Strategies Using Monoclonal Antibodies and Tyrosine Kinase Inhibitors

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

CARF, As An Oncogene, Promotes Colorectal Cancer Stemness By Activating ERBB Signaling Pathway

;OncoTargets and Therapy;2019-11

2. Dual silencing of EGFR and HER2 enhances the sensitivity of gastric cancer cells to gefitinib;Molecular Carcinogenesis;2018-04-24

3. Dual targeting of HER3 and EGFR in colorectal tumors might overcome anti-EGFR resistance;Critical Reviews in Oncology/Hematology;2016-05

4. Phenotypic Knockout of CXCR4 Expression by a Novel Intrakine Mutant hSDF-1α/54/KDEL Inhibits Breast Cancer Metastasis;Journal of Interferon & Cytokine Research;2015-10

5. The promise of anti-ErbB3 monoclonals as new cancer therapeutics;Oncotarget;2012-08-10